Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
First Community Bankshares
FCBC
$924M
| $520K | ﹤0.01% |
15,339
-4,854
| -24% | -$173K |
|
3202
Douglas Dynamics
PLOW
$1.03B
| $517K | ﹤0.01% |
14,292
-4,174
| -23% | -$147K |
|
|
FBRT
3203
Franklin BSP Realty Trust
FBRT
$639M
| $516K | ﹤0.01% |
40,023
+18,292
| +84% | +$245K |
|
3204
Amalgamated Financial
AMAL
$1.49B
| $516K | ﹤0.01% |
22,376
+8,665
| +63% | +$210K |
|
|
VLD
3205
DELISTED
Velo3D, Inc.
VLD
| $515K | ﹤0.01% |
8,227
+1,371
| +20% | +$133K |
|
|
AVEO
3206
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $515K | ﹤0.01% |
34,444
+26,622
| +340% | +$369K |
|
3207
Paysafe
PSFE
$405M
| $515K | ﹤0.01% |
37,043
+9,864
| +36% | +$159K |
|
3208
Miller Industries
MLR
$579M
| $514K | ﹤0.01% |
19,278
+2,507
| +15% | +$64.2K |
|
3209
Pliant Therapeutics
PLRX
$65M
| $513K | ﹤0.01% |
26,515
+20,919
| +374% | +$437K |
|
3210
Tactile Systems Technology
TCMD
$680M
| $511K | ﹤0.01% |
44,552
+12,610
| +39% | +$111K |
|
|
ZUO
3211
DELISTED
Zuora, Inc.
ZUO
| $511K | ﹤0.01% |
80,325
+8,994
| +13% | +$63.6K |
|
|
CRZN
3212
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
| $511K | ﹤0.01% |
50,648
| – | – |
|
3213
US Physical Therapy
USPH
$1.15B
| $506K | ﹤0.01% |
6,248
+2,811
| +82% | +$236K |
|
3214
Transmedics
TMDX
$2.79B
| $506K | ﹤0.01% |
8,194
+6,900
| +533% | +$367K |
|
3215
Schrodinger
SDGR
$1.17B
| $503K | ﹤0.01% |
26,933
+6,466
| +32% | +$134K |
|
3216
Clear Secure
YOU
$5.62B
| $501K | ﹤0.01% |
18,254
+10,125
| +125% | +$279K |
|
3217
AB InBev
BUD
$167B
| $500K | ﹤0.01% |
8,332
-23,361
| -74% | -$1.25M |
|
3218
Stock Yards Bancorp
SYBT
$2.65B
| $500K | ﹤0.01% |
7,688
+6,474
| +533% | +$463K |
|
3219
SmartFinancial
SMBK
$910M
| $498K | ﹤0.01% |
18,120
-17,525
| -49% | -$492K |
|
3220
Hayward Holdings
HAYW
$3.41B
| $498K | ﹤0.01% |
52,974
-43,460
| -45% | -$404K |
|
|
MCBC
3221
DELISTED
Macatawa Bank Corp
MCBC
| $498K | ﹤0.01% |
45,106
-3,579
| -7% | -$38K |
|
3222
Boot Barn
BOOT
$4.94B
| $496K | ﹤0.01% |
7,927
-9,186
| -54% | -$551K |
|
3223
Forrester Research
FORR
$228M
| $495K | ﹤0.01% |
13,849
-4,284
| -24% | -$157K |
|
3224
Monarch Casino & Resort
MCRI
$2.25B
| $494K | ﹤0.01% |
6,429
+2,916
| +83% | +$220K |
|
3225
MP Materials
MP
$8.45B
| $494K | ﹤0.01% |
20,358
-13,691
| -40% | -$415K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.